{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-050753","form_type":"8-K","ticker":"OPRX","cik":"0001448431","company_name":"OptimizeRx Corp","filed_at":"2024-06-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.464577+00:00","generated_at":"2026-06-01T05:32:03.040121+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"OptimizeRx shareholders approve 1.95M share increase to equity plan at annual meeting","bullets":["Shareholders approved amendment to 2021 Equity Plan increasing share pool from 2.5M to 4.45M shares (increase of 1.95M).","Equity plan vote: 10,129,247 for, 3,425,566 against, 8,853 abstain, 1,966,973 broker non-votes.","All six director nominees elected; advisory say-on-pay approved with 8,790,190 for votes.","UHY LLP ratified as independent auditor for fiscal 2024 with 13,628,263 votes for, 24,012 against, 1,878,364 abstain."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-050753","json":"https://secwatch.observer/filing/0001213900-24-050753.json","markdown":"https://secwatch.observer/filing/0001213900-24-050753.md","text":"https://secwatch.observer/filing/0001213900-24-050753.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1448431/000121390024050753/0001213900-24-050753-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1448431/000121390024050753/ea0207524-8k_optimize.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T05:32:03.040121+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}